Additional Documents
1 PDF: Department of Veterans’ Affairs, Answers to questions on notice following the Brisbane and Townsville public hearings on 30 and 31 August 2018, received 9 October 2018. Department of Veterans’ Affairs, Answers to questions on notice following the Brisbane and Townsville public hearings on 30 and 31 August 2018, received 9 October 2018.
2 PDF: Royal Australian College of General Practitioners, Answers to questions taken on notice at 11 October 2018 hearing in Canberra, received 31 October 2018. Royal Australian College of General Practitioners, Answers to questions taken on notice at 11 October 2018 hearing in Canberra, received 31 October 2018.
3 PDF: Department of Veterans’ Affairs, Answers to questions taken on notice at 11 October 2018 hearing in Canberra, received 1 November 2018. Department of Veterans’ Affairs, Answers to questions taken on notice at 11 October 2018 hearing in Canberra, received 1 November 2018.
4 PDF: Department of Defence, Answers to written questions on notice, received 6 November 2018. Department of Defence, Answers to written questions on notice, received 6 November 2018.
5 PDF: Roche Products Pty Ltd, Answers to questions taken on notice at 8 November 2018 hearing in Canberra, received 19 November 2018. Roche Products Pty Ltd, Answers to questions taken on notice at 8 November 2018 hearing in Canberra, received 19 November 2018.
6 PDF: Department of Health, Answers to questions taken on notice at 11 October 2018 hearing in Canberra, received on 16 November 2018. Department of Health, Answers to questions taken on notice at 11 October 2018 hearing in Canberra, received on 16 November 2018.
7 PDF: GlaxoSmithKline Australia Pty Ltd, Answers to questions taken on notice at 8 November 2018 hearing in Canberra, received 21 November 2018. GlaxoSmithKline Australia Pty Ltd, Answers to questions taken on notice at 8 November 2018 hearing in Canberra, received 21 November 2018.
8 PDF: Department of Defence, Answers to written questions on notice, received 11 December 2018. Department of Defence, Answers to written questions on notice, received 11 December 2018.
9 PDF: Department of Defence, Answers to written questions on notice from 30-31 August 2018 hearings in QLD, received 6 February 2019. Department of Defence, Answers to written questions on notice from 30-31 August 2018 hearings in QLD, received 6 February 2019.
10 PDF: Department of Defence, Answers to questions on notice from 11 October 2018 hearing, received 6 February 2019. Department of Defence, Answers to questions on notice from 11 October 2018 hearing, received 6 February 2019.
11 PDF: Department of Defence, Answers to questions on notice from 5 November 2018 hearing, received 6 February 2019. Department of Defence, Answers to questions on notice from 5 November 2018 hearing, received 6 February 2019.

See Also

Other information presented to the inquiry

Committee Secretariat contact:

Foreign Affairs, Defence and Trade Committee
Department of the Senate
PO Box 6100
Parliament House
Canberra ACT 2600

Phone: +61 2 6277 3535
fadt.sen@aph.gov.au

About this inquiry

Inquiry into the use of the Quinoline anti-malarial drugs Mefloquine and Tafenoquine in the Australian Defence Force.



Past Public Hearings

08 Nov 2018: Canberra
05 Nov 2018: Melbourne
15 Oct 2018: Canberra

more...

Inquiry Status

Report Tabled

Accessibility

We are committed to ensuring that everyone who wishes to can participate in the Committee’s inquiry. If you have accessibility requirements, please contact the Committee Secretariat.

Further information regarding accessibility can be found at www.aph.gov.au/Help/Accessibility